Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

A big FDA approval for Boston Scientific | New-look TAVR valve impresses | Automated PCI risk assessments

News You Need to Know Today
A big FDA approval for Boston Scientific | New-look TAVR valve impresses | Automated PCI risk assessments
Tuesday, July 8, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA expands approval of Boston Scientific’s Farapulse PFA system

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms. 

READ MORE >
The Farapulse Boston Scientific Pulsed Field Ablation (PFA) system gained U.S. FDA approval in early 2024.
Share on Twitter Share on Facebook Share on Linkedin

FDA expands approval of Boston Scientific’s Farapulse PFA system

Share on Twitter Share on Facebook Share on Linkedin
The Farapulse Boston Scientific Pulsed Field Ablation (PFA) system gained U.S. FDA approval in early 2024.
The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms. 
READ MORE >

New TAVR valve from MiRus linked to positive early outcomes

The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus. 

READ MORE >
MiRus Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus.
Share on Twitter Share on Facebook Share on Linkedin

New TAVR valve from MiRus linked to positive early outcomes

Share on Twitter Share on Facebook Share on Linkedin
MiRus Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus.
The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus. 
READ MORE >

EHR-driven PCI risk assessments could make a world of difference

Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients. 

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

EHR-driven PCI risk assessments could make a world of difference

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients. 
READ MORE >

Featured Articles

Beloved cardiologist killed in airstrike—he was one of Gaza’s last heart doctors

A prominent doctor and multiple family members are dead after an Israeli airstrike. "Thousands of heart patients will suffer as a result of his killing," one colleague said.

READ MORE >
Dr. Marwan al-Sultan
Share on Twitter Share on Facebook Share on Linkedin

Beloved cardiologist killed in airstrike—he was one of Gaza’s last heart doctors

Share on Twitter Share on Facebook Share on Linkedin
Dr. Marwan al-Sultan
A prominent doctor and multiple family members are dead after an Israeli airstrike. "Thousands of heart patients will suffer as a result of his killing," one colleague said.
READ MORE >

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients

It may not always be necessary to subject heart transplant patients to one biopsy after another. 

READ MORE >
blood test research laboratory
Share on Twitter Share on Facebook Share on Linkedin

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients

Share on Twitter Share on Facebook Share on Linkedin
blood test research laboratory
It may not always be necessary to subject heart transplant patients to one biopsy after another. 
READ MORE >

Radiation in the cath lab: Tracking state-level regulations for cardiologists

Researchers hope these policies can be standardized in the future to help avoid confusion and improve clinician safety.

READ MORE >
USA
Share on Twitter Share on Facebook Share on Linkedin

Radiation in the cath lab: Tracking state-level regulations for cardiologists

Share on Twitter Share on Facebook Share on Linkedin
USA
Researchers hope these policies can be standardized in the future to help avoid confusion and improve clinician safety.
READ MORE >

In Case You Missed It

Cannabis is bad for the heart—should the risk be taken more seriously?

Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and highlighted the importance of discussing these risks with patients.

READ MORE >
cannabis use disorder marijuana joint weed smoking
Share on Twitter Share on Facebook Share on Linkedin

Cannabis is bad for the heart—should the risk be taken more seriously?

Share on Twitter Share on Facebook Share on Linkedin
cannabis use disorder marijuana joint weed smoking
Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and highlighted the importance of discussing these risks with patients.
READ MORE >

AI model gets helpful heart assessments out of nongated CT scans

"Using AI for tasks like CAC detection can help shift medicine from a reactive approach to the proactive prevention of disease," one researcher said.

READ MORE >
artificial intelligence heart AI
Share on Twitter Share on Facebook Share on Linkedin

AI model gets helpful heart assessments out of nongated CT scans

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence heart AI
"Using AI for tasks like CAC detection can help shift medicine from a reactive approach to the proactive prevention of disease," one researcher said.
READ MORE >

TAVR patients with moderate or greater TR may face increased risks

When TAVR patients present with moderate or greater tricuspid regurgitation, it could impact the care team's treatment strategy of choice.

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

TAVR patients with moderate or greater TR may face increased risks

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
When TAVR patients present with moderate or greater tricuspid regurgitation, it could impact the care team's treatment strategy of choice.
READ MORE >

In Other News

Private equity firm buys health data analytics company Arcadia

With the buyout, global private equity investor Nordic Capital makes a big bet on healthcare AI. Arcadia said the influx of cash will be used to improve its technology and find new sources for data it can use for quality care initiatives. 

READ MORE >
merger acquisition M&A business
Share on Twitter Share on Facebook Share on Linkedin

Private equity firm buys health data analytics company Arcadia

Share on Twitter Share on Facebook Share on Linkedin
merger acquisition M&A business
With the buyout, global private equity investor Nordic Capital makes a big bet on healthcare AI. Arcadia said the influx of cash will be used to improve its technology and find new sources for data it can use for quality care initiatives. 
READ MORE >

Survey unearths confusion among women around when to start mammograms

Among 1,600 U.S. adults surveyed, about 49% said they know that age 40 is when women at average risk should begin screening. 

READ MORE >
Interval breast cancer rates on the rise.
Share on Twitter Share on Facebook Share on Linkedin

Survey unearths confusion among women around when to start mammograms

Share on Twitter Share on Facebook Share on Linkedin
Interval breast cancer rates on the rise.
Among 1,600 U.S. adults surveyed, about 49% said they know that age 40 is when women at average risk should begin screening. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup